Biomarkers

August 11, 2017

Blood MicroRNA Levels May Help Diagnose MPM and Asbestosis, Pilot Study Finds

Researchers have found that patients with malignant pleural mesothelioma (MPM) and asbestosis — a chronic lung disease caused by asbestos inhalation — have low levels of certain microRNAs (miRNAs) in ... Read more

June 9, 2017

Researchers Aim to Improve Diagnosis of Malignant Pleural Mesothelioma

News

A study has tried to overcome the challenges in the diagnosis of patients with malignant pleural mesothelioma (MPM) through the detection of two biomarkers in pleural effusions and in peripheral ... Read more

May 19, 2017May 19, 2017

High Mesothelin Levels Linked to Poor Prognosis in Malignant Pleural Mesothelioma Patients, Study Reports

News

Soluble mesothelin, a cell surface glycoprotein predominant in several types of cancer, is an independent prognostic marker and a new potential therapeutic target for patients with malignant pleural mesothelioma ... Read more

May 12, 2017

Study Identifies Blood Biomarkers for Diagnosing Early MPM

News

Two potential biomarkers have been identified for the diagnosis of early malignant pleural mesothelioma (MPM) in a study that compared the differences in microRNA (miRNA) expression between MPM patients ... Read more

April 20, 2017April 20, 2017

Combination of Blood Biomarkers May Speed Diagnosis of Malignant Mesothelioma

News

Detecting a combination of biomarkers already linked to malignant mesothelioma may significantly improve the sensitivity and specificity of screening tests, allowing a more accurate and reliable early diagnosis, new research reports. The study, ... Read more

April 12, 2017

New Tissue Imaging and Collecting Technique Can Identify Mesothelioma Subtypes

News

German researchers have come up with a new tissue-sample imaging and collecting technique for identifying diffuse malignant mesothelioma (DMM) subtypes. The method that the team at Ruhr-University Bochum developed is based ... Read more

March 9, 2017

Researchers Develop More Feasible Method for Distinguishing MPM from Benign RMH

News

Immunohistochemistry, an imaging technique to detect the loss of two proteins, MTAP and BAP1, may help doctors distinguish between malignant pleural mesothelioma (MPM) and reactive mesothelial hyperplasia (RMH), according to ... Read more

December 13, 2016

Researchers Identify 2 Proteins That Could Help Detect Malignant Mesothelioma

News

Loss of the BAP1 protein and high levels of the EZH2 protein are two very specific characteristics of malignant mesothelioma and may serve as biomarkers to help researchers differentiate ... Read more

April 21, 2016April 21, 2016

Researchers in Hawaii Receive $3M to Study Biomarkers, Vaccines and Mutations in Malignant Mesothelioma

News

Investigators at the University of Hawai‘i (UH) Cancer Center and its John A. Burns School of Medicine (JABSOM) have been awarded three grants by the United States Department of Defense (DoD) for research ... Read more

April 20, 2016April 20, 2016

Study Identifies 2 Serum Biomarkers That Might Quickly Detect Malignant Mesothelioma Caused by Asbestos Exposure

News

Two serum biomarkers, soluble mesothelin-related peptide (SMRP) and thioredoxin-1 (TRX), were identified as potentially useful for an early diagnosis of malignant pleural mesothelioma, according to the study, “Evaluation of ... Read more